Novel analgesic mechanism to be explored in Japanese collaboration

27 March 2018

Tokyo’s Asahi Kasei Pharma and fellow Japanese firm RaQualia Pharma have entered into a license agreement for a novel P2X7 receptor antagonist.

The candidate was discovered jointly as part of an ongoing research collaboration started in November 2013. RaQualia Pharma is a Nagoya-based firm specializing in ion channel drug discovery technology.

Exhibiting an analgesic effect with a different mechanism from existing drugs, the companies hope that AKP-23494954/RQ-00466479 will become an innovative new drug for neuropathic pain.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK